Your session is about to expire
← Back to Search
Staff training and academic detailing for Tobacco Use
N/A
Waitlist Available
Led By Scott E. Sherman, MD MPH
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2-year intervention period
Awards & highlights
Study Summary
This trial will study whether an opt-out or opt-in approach is more effective in referring smokers to treatment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2-year intervention period
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2-year intervention period
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Abstinence at the end of the 2-year intervention period
Proportion of smokers who accept referral to treatment (Quitline or text messaging)
Proportion of smokers who engage in treatment with the Quitline or text messaging service
Secondary outcome measures
Cost-effectiveness of the two approaches (opt-out vs opt-in)
Use of smoking cessation medications
Trial Design
2Treatment groups
Experimental Treatment
Group I: Opt-out tobacco treatmentExperimental Treatment1 Intervention
The investigators will directly change the treatment status quo by implementing a clinical reminder that automatically initiates tobacco treatment referral at the time the reminder is activated.
Group II: Opt-in clinical reminderExperimental Treatment1 Intervention
As the investigators have done previously, the reminder will be self-explanatory, and will walk staff through each step of referral. The reminder will include the following domains: normative advice, referral to treatment, handout
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,605 Previous Clinical Trials
3,304,231 Total Patients Enrolled
4 Trials studying Tobacco Use
3,669 Patients Enrolled for Tobacco Use
Scott E. Sherman, MD MPHPrincipal InvestigatorManhattan Campus of the VA NY Harbor Healthcare System, New York, NY
1 Previous Clinical Trials
220 Total Patients Enrolled
Steven S. Fu, MD MSCEPrincipal InvestigatorMinneapolis VA Health Care System, Minneapolis, MN
3 Previous Clinical Trials
10,714 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Opt-in clinical reminder
- Group 2: Opt-out tobacco treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are researchers still accepting participants for this experiment?
"From the data hosted on clinicaltrials.gov, it is apparent that this study has ceased to recruit patients; with a first post date of August 28th 2019 and its last update being August 3rd 2022. Nevertheless, there are still 55 other studies actively enrolling participants as we speak."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger